APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genetically Modified Animal Models

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Genetically Modified Animal Models Market Outlook and Growth Opportunities 2026

2 May 2026193 pages

Choose your research edition.

Industry ResearchGenetically Modified Animal Models Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Genetically Modified Animal Models Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Genetically Modified Animal Models Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genetically Modified Animal Models Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Genetically Modified Animal Models Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Genetically Modified Animal Models market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Genetically Modified Animal Models market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Genetically Modified Animal Models market include ModelOrg, GemPharmatech, Cyagen Biosciences, Biocytogen, JOINN, China Environmental Technology and Bioenergy, Charles River, Taconic Biosciences and GenOway, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Genetically Modified Animal Models market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genetically Modified Animal Models and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genetically Modified Animal Models revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Genetically Modified Animal Models market.

Genetically Modified Animal Models Segment by Company

ModelOrg

GemPharmatech

Cyagen Biosciences

Biocytogen

JOINN

China Environmental Technology and Bioenergy

Charles River

Taconic Biosciences

GenOway

CLEA Japan

Ozgene

InVivo Biosystems

Harbour BioMed

PolyGene

Genetically Modified Animal Models Segment by Type

Rodents

Non-Human Primates

Zebrafish

Others

Genetically Modified Animal Models Segment by Application

Universities

Hospitals

Pharmaceutical Companies

Others

Genetically Modified Animal Models Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Genetically Modified Animal Models status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Genetically Modified Animal Models key companies, revenue, market share, and recent developments.

3. To split the Genetically Modified Animal Models breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Genetically Modified Animal Models market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Genetically Modified Animal Models significant trends, drivers, influence factors in global and regions.

6. To analyze Genetically Modified Animal Models competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetically Modified Animal Models market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetically Modified Animal Models and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetically Modified Animal Models.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genetically Modified Animal Models industry.

Chapter 3: Detailed analysis of Genetically Modified Animal Models company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Genetically Modified Animal Models in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Genetically Modified Animal Models in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Genetically Modified Animal Models Industry Trends Table 2. Genetically Modified Animal Models Industry Drivers Table 3. Genetically Modified Animal Models Industry Opportunities and Challenges Table 4. Genetically Modified Animal Models Industry Restraints Table 5. Global Genetically Modified Animal Models Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Genetically Modified Animal Models Revenue Share by Company (2021-2026) Table 7. Global Genetically Modified Animal Models Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Genetically Modified Animal Models Key Company Manufacturing Base & Headquarters Table 9. Global Genetically Modified Animal Models Company, Product Type & Application Table 10. Global Genetically Modified Animal Models Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Genetically Modified Animal Models by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Rodents Table 15. Significant Companies of Non-Human Primates Table 16. Significant Companies of Zebrafish Table 17. Significant Companies of Others Table 18. Global Genetically Modified Animal Models Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Genetically Modified Animal Models Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Genetically Modified Animal Models Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Genetically Modified Animal Models Sales Value Share by Type (2021-2026) Table 22. Global Genetically Modified Animal Models Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Universities Table 24. Significant Companies of Hospitals Table 25. Significant Companies of Pharmaceutical Companies Table 26. Significant Companies of Others Table 27. Global Genetically Modified Animal Models Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Genetically Modified Animal Models Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Genetically Modified Animal Models Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Genetically Modified Animal Models Sales Value Share by Application (2021-2026) Table 31. Global Genetically Modified Animal Models Sales Value Share by Application (2027-2032) Table 32. Global Genetically Modified Animal Models Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Genetically Modified Animal Models Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Genetically Modified Animal Models Sales Value Share by Region (2021-2026) Table 35. Global Genetically Modified Animal Models Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Genetically Modified Animal Models Sales Value Share by Region (2027-2032) Table 37. Global Genetically Modified Animal Models Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Genetically Modified Animal Models Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Genetically Modified Animal Models Sales Value Market Share by Country (2021-2026) Table 40. Global Genetically Modified Animal Models Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Genetically Modified Animal Models Sales Value Market Share by Country (2027-2032) Table 42. ModelOrg Company Information Table 43. ModelOrg Business Overview Table 44. ModelOrg Genetically Modified Animal Models Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. ModelOrg Genetically Modified Animal Models Product Portfolio Table 46. ModelOrg Recent Development Table 47. GemPharmatech Company Information Table 48. GemPharmatech Business Overview Table 49. GemPharmatech Genetically Modified Animal Models Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. GemPharmatech Genetically Modified Animal Models Product Portfolio Table 51. GemPharmatech Recent Development Table 52. Cyagen Biosciences Company Information Table 53. Cyagen Biosciences Business Overview Table 54. Cyagen Biosciences Genetically Modified Animal Models Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Cyagen Biosciences Genetically Modified Animal Models Product Portfolio Table 56. Cyagen Biosciences Recent Development Table 57. Biocytogen Company Information Table 58. Biocytogen Business Overview Table 59. Biocytogen Genetically Modified Animal Models Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Biocytogen Genetically Modified Animal Models Product Portfolio Table 61. Biocytogen Recent Development Table 62. JOINN Company Information Table 63. JOINN Business Overview Table 64. JOINN Genetically Modified Animal Models Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. JOINN Genetically Modified Animal Models Product Portfolio Table 66. JOINN Recent Development Table 67. China Environmental Technology and Bioenergy Company Information Table 68. China Environmental Technology and Bioenergy Business Overview Table 69. China Environmental Technology and Bioenergy Genetically Modified Animal Models Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. China Environmental Technology and Bioenergy Genetically Modified Animal Models Product Portfolio Table 71. China Environmental Technology and Bioenergy Recent Development Table 72. Charles River Company Information Table 73. Charles River Business Overview Table 74. Charles River Genetically Modified Animal Models Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Charles River Genetically Modified Animal Models Product Portfolio Table 76. Charles River Recent Development Table 77. Taconic Biosciences Company Information Table 78. Taconic Biosciences Business Overview Table 79. Taconic Biosciences Genetically Modified Animal Models Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Taconic Biosciences Genetically Modified Animal Models Product Portfolio Table 81. Taconic Biosciences Recent Development Table 82. GenOway Company Information Table 83. GenOway Business Overview Table 84. GenOway Genetically Modified Animal Models Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. GenOway Genetically Modified Animal Models Product Portfolio Table 86. GenOway Recent Development Table 87. CLEA Japan Company Information Table 88. CLEA Japan Business Overview Table 89. CLEA Japan Genetically Modified Animal Models Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. CLEA Japan Genetically Modified Animal Models Product Portfolio Table 91. CLEA Japan Recent Development Table 92. Ozgene Company Information Table 93. Ozgene Business Overview Table 94. Ozgene Genetically Modified Animal Models Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Ozgene Genetically Modified Animal Models Product Portfolio Table 96. Ozgene Recent Development Table 97. InVivo Biosystems Company Information Table 98. InVivo Biosystems Business Overview Table 99. InVivo Biosystems Genetically Modified Animal Models Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. InVivo Biosystems Genetically Modified Animal Models Product Portfolio Table 101. InVivo Biosystems Recent Development Table 102. Harbour BioMed Company Information Table 103. Harbour BioMed Business Overview Table 104. Harbour BioMed Genetically Modified Animal Models Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Harbour BioMed Genetically Modified Animal Models Product Portfolio Table 106. Harbour BioMed Recent Development Table 107. PolyGene Company Information Table 108. PolyGene Business Overview Table 109. PolyGene Genetically Modified Animal Models Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. PolyGene Genetically Modified Animal Models Product Portfolio Table 111. PolyGene Recent Development Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Genetically Modified Animal Models Product Image Figure 2. Global Genetically Modified Animal Models Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genetically Modified Animal Models Market Size (2021-2032) & (US$ Million) Figure 4. Global Genetically Modified Animal Models Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Rodents Image Figure 8. Non-Human Primates Image Figure 9. Zebrafish Image Figure 10. Others Image Figure 11. Global Genetically Modified Animal Models Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Genetically Modified Animal Models Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Genetically Modified Animal Models Sales Value Share by Type (2021-2032) Figure 14. Universities Image Figure 15. Hospitals Image Figure 16. Pharmaceutical Companies Image Figure 17. Others Image Figure 18. Global Genetically Modified Animal Models Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Genetically Modified Animal Models Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Genetically Modified Animal Models Sales Value Share by Application (2021-2032) Figure 21. Global Genetically Modified Animal Models Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Genetically Modified Animal Models Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Genetically Modified Animal Models Sales Value (2021-2032) & (US$ Million) Figure 24. North America Genetically Modified Animal Models Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Genetically Modified Animal Models Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Genetically Modified Animal Models Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Genetically Modified Animal Models Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Genetically Modified Animal Models Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Genetically Modified Animal Models Sales Value (2021-2032) & (US$ Million) Figure 30. South America Genetically Modified Animal Models Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Genetically Modified Animal Models Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Genetically Modified Animal Models Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Genetically Modified Animal Models Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Rodents
  • Non-Human Primates
  • Zebrafish
  • Others
Applications
  • Universities
  • Hospitals
  • Pharmaceutical Companies
  • Others
Companies covered
  • ModelOrg
  • GemPharmatech
  • Cyagen Biosciences
  • Biocytogen
  • JOINN
  • China Environmental Technology and Bioenergy
  • Charles River
  • Taconic Biosciences
  • GenOway
  • CLEA Japan
  • Ozgene
  • InVivo Biosystems
  • Harbour BioMed
  • PolyGene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Genetically Modified Animal Models Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Genetically Modified Animal Models Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Genetically Modified Animal Models Market Dynamics
  1. 2.1 Genetically Modified Animal Models Industry Trends
  2. 2.2 Genetically Modified Animal Models Industry Drivers
  3. 2.3 Genetically Modified Animal Models Industry Opportunities and Challenges
  4. 2.4 Genetically Modified Animal Models Industry Restraints
3 Genetically Modified Animal Models Market by Company
  1. 3.1 Global Genetically Modified Animal Models Company Revenue Ranking in 2025
  2. 3.2 Global Genetically Modified Animal Models Revenue by Company (2021-2026)
  3. 3.3 Global Genetically Modified Animal Models Company Ranking (2024-2026)
  4. 3.4 Global Genetically Modified Animal Models Company Manufacturing Base and Headquarters
  5. 3.5 Global Genetically Modified Animal Models Company Product Type and Application
  6. 3.6 Global Genetically Modified Animal Models Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Genetically Modified Animal Models Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Genetically Modified Animal Models Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Genetically Modified Animal Models Market by Type
  1. 4.1 Genetically Modified Animal Models Type Introduction
  2. 4.1.1 Rodents
  3. 4.1.2 Non-Human Primates
  4. 4.1.3 Zebrafish
  5. 4.1.4 Others
  6. 4.2 Global Genetically Modified Animal Models Sales Value by Type
  7. 4.2.1 Global Genetically Modified Animal Models Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Genetically Modified Animal Models Sales Value by Type (2021-2032)
  9. 4.2.3 Global Genetically Modified Animal Models Sales Value Share by Type (2021-2032)
5 Genetically Modified Animal Models Market by Application
  1. 5.1 Genetically Modified Animal Models Application Introduction
  2. 5.1.1 Universities
  3. 5.1.2 Hospitals
  4. 5.1.3 Pharmaceutical Companies
  5. 5.1.4 Others
  6. 5.2 Global Genetically Modified Animal Models Sales Value by Application
  7. 5.2.1 Global Genetically Modified Animal Models Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Genetically Modified Animal Models Sales Value by Application (2021-2032)
  9. 5.2.3 Global Genetically Modified Animal Models Sales Value Share by Application (2021-2032)
6 Genetically Modified Animal Models Regional Value Analysis
  1. 6.1 Global Genetically Modified Animal Models Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Genetically Modified Animal Models Sales Value by Region (2021-2032)
  3. 6.2.1 Global Genetically Modified Animal Models Sales Value by Region: 2021-2026
  4. 6.2.2 Global Genetically Modified Animal Models Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Genetically Modified Animal Models Sales Value (2021-2032)
  7. 6.3.2 North America Genetically Modified Animal Models Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Genetically Modified Animal Models Sales Value (2021-2032)
  10. 6.4.2 Europe Genetically Modified Animal Models Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Genetically Modified Animal Models Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Genetically Modified Animal Models Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Genetically Modified Animal Models Sales Value (2021-2032)
  16. 6.6.2 South America Genetically Modified Animal Models Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Genetically Modified Animal Models Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Genetically Modified Animal Models Sales Value Share by Country, 2025 VS 2032
7 Genetically Modified Animal Models Country-level Value Analysis
  1. 7.1 Global Genetically Modified Animal Models Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Genetically Modified Animal Models Sales Value by Country (2021-2032)
  3. 7.2.1 Global Genetically Modified Animal Models Sales Value by Country (2021-2026)
  4. 7.2.2 Global Genetically Modified Animal Models Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Genetically Modified Animal Models Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Genetically Modified Animal Models Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Genetically Modified Animal Models Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ModelOrg
  2. 8.1.1 ModelOrg Company Information
  3. 8.1.2 ModelOrg Business Overview
  4. 8.1.3 ModelOrg Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ModelOrg Genetically Modified Animal Models Product Portfolio
  6. 8.1.5 ModelOrg Recent Developments
  7. 8.2 GemPharmatech
  8. 8.2.1 GemPharmatech Company Information
  9. 8.2.2 GemPharmatech Business Overview
  10. 8.2.3 GemPharmatech Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GemPharmatech Genetically Modified Animal Models Product Portfolio
  12. 8.2.5 GemPharmatech Recent Developments
  13. 8.3 Cyagen Biosciences
  14. 8.3.1 Cyagen Biosciences Company Information
  15. 8.3.2 Cyagen Biosciences Business Overview
  16. 8.3.3 Cyagen Biosciences Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cyagen Biosciences Genetically Modified Animal Models Product Portfolio
  18. 8.3.5 Cyagen Biosciences Recent Developments
  19. 8.4 Biocytogen
  20. 8.4.1 Biocytogen Company Information
  21. 8.4.2 Biocytogen Business Overview
  22. 8.4.3 Biocytogen Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biocytogen Genetically Modified Animal Models Product Portfolio
  24. 8.4.5 Biocytogen Recent Developments
  25. 8.5 JOINN
  26. 8.5.1 JOINN Company Information
  27. 8.5.2 JOINN Business Overview
  28. 8.5.3 JOINN Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  29. 8.5.4 JOINN Genetically Modified Animal Models Product Portfolio
  30. 8.5.5 JOINN Recent Developments
  31. 8.6 China Environmental Technology and Bioenergy
  32. 8.6.1 China Environmental Technology and Bioenergy Company Information
  33. 8.6.2 China Environmental Technology and Bioenergy Business Overview
  34. 8.6.3 China Environmental Technology and Bioenergy Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  35. 8.6.4 China Environmental Technology and Bioenergy Genetically Modified Animal Models Product Portfolio
  36. 8.6.5 China Environmental Technology and Bioenergy Recent Developments
  37. 8.7 Charles River
  38. 8.7.1 Charles River Company Information
  39. 8.7.2 Charles River Business Overview
  40. 8.7.3 Charles River Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Charles River Genetically Modified Animal Models Product Portfolio
  42. 8.7.5 Charles River Recent Developments
  43. 8.8 Taconic Biosciences
  44. 8.8.1 Taconic Biosciences Company Information
  45. 8.8.2 Taconic Biosciences Business Overview
  46. 8.8.3 Taconic Biosciences Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Taconic Biosciences Genetically Modified Animal Models Product Portfolio
  48. 8.8.5 Taconic Biosciences Recent Developments
  49. 8.9 GenOway
  50. 8.9.1 GenOway Company Information
  51. 8.9.2 GenOway Business Overview
  52. 8.9.3 GenOway Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GenOway Genetically Modified Animal Models Product Portfolio
  54. 8.9.5 GenOway Recent Developments
  55. 8.10 CLEA Japan
  56. 8.10.1 CLEA Japan Company Information
  57. 8.10.2 CLEA Japan Business Overview
  58. 8.10.3 CLEA Japan Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CLEA Japan Genetically Modified Animal Models Product Portfolio
  60. 8.10.5 CLEA Japan Recent Developments
  61. 8.11 Ozgene
  62. 8.11.1 Ozgene Company Information
  63. 8.11.2 Ozgene Business Overview
  64. 8.11.3 Ozgene Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ozgene Genetically Modified Animal Models Product Portfolio
  66. 8.11.5 Ozgene Recent Developments
  67. 8.12 InVivo Biosystems
  68. 8.12.1 InVivo Biosystems Company Information
  69. 8.12.2 InVivo Biosystems Business Overview
  70. 8.12.3 InVivo Biosystems Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  71. 8.12.4 InVivo Biosystems Genetically Modified Animal Models Product Portfolio
  72. 8.12.5 InVivo Biosystems Recent Developments
  73. 8.13 Harbour BioMed
  74. 8.13.1 Harbour BioMed Company Information
  75. 8.13.2 Harbour BioMed Business Overview
  76. 8.13.3 Harbour BioMed Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Harbour BioMed Genetically Modified Animal Models Product Portfolio
  78. 8.13.5 Harbour BioMed Recent Developments
  79. 8.14 PolyGene
  80. 8.14.1 PolyGene Company Information
  81. 8.14.2 PolyGene Business Overview
  82. 8.14.3 PolyGene Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  83. 8.14.4 PolyGene Genetically Modified Animal Models Product Portfolio
  84. 8.14.5 PolyGene Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst